CN108968072A - Linolenic acid microcapsule powder and preparation method thereof and application method - Google Patents
Linolenic acid microcapsule powder and preparation method thereof and application method Download PDFInfo
- Publication number
- CN108968072A CN108968072A CN201811192556.XA CN201811192556A CN108968072A CN 108968072 A CN108968072 A CN 108968072A CN 201811192556 A CN201811192556 A CN 201811192556A CN 108968072 A CN108968072 A CN 108968072A
- Authority
- CN
- China
- Prior art keywords
- parts
- vitamin
- linolenic acid
- powder
- microcapsule powder
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000000843 powder Substances 0.000 title claims abstract description 89
- 239000003094 microcapsule Substances 0.000 title claims abstract description 63
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 title claims abstract description 61
- 235000020661 alpha-linolenic acid Nutrition 0.000 title claims abstract description 49
- 229960004488 linolenic acid Drugs 0.000 title claims abstract description 49
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 title claims abstract description 37
- 238000000034 method Methods 0.000 title claims abstract description 11
- 238000002360 preparation method Methods 0.000 title claims abstract description 8
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 30
- 235000021388 linseed oil Nutrition 0.000 claims abstract description 29
- 239000000944 linseed oil Substances 0.000 claims abstract description 29
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000011575 calcium Substances 0.000 claims abstract description 17
- 229910052791 calcium Inorganic materials 0.000 claims abstract description 17
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 15
- 229960000304 folic acid Drugs 0.000 claims abstract description 15
- 235000019152 folic acid Nutrition 0.000 claims abstract description 15
- 239000011724 folic acid Substances 0.000 claims abstract description 15
- 239000000463 material Substances 0.000 claims abstract description 5
- 229940088594 vitamin Drugs 0.000 claims abstract description 4
- 229930003231 vitamin Natural products 0.000 claims abstract description 4
- 235000013343 vitamin Nutrition 0.000 claims abstract description 4
- 239000011782 vitamin Substances 0.000 claims abstract description 4
- 150000003722 vitamin derivatives Chemical class 0.000 claims abstract description 4
- XOAAWQZATWQOTB-UHFFFAOYSA-N taurine Chemical compound NCCS(O)(=O)=O XOAAWQZATWQOTB-UHFFFAOYSA-N 0.000 claims description 50
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 claims description 44
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 38
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 36
- DLRVVLDZNNYCBX-UHFFFAOYSA-N Polydextrose Polymers OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(O)O1 DLRVVLDZNNYCBX-UHFFFAOYSA-N 0.000 claims description 30
- GHOKWGTUZJEAQD-ZETCQYMHSA-N (D)-(+)-Pantothenic acid Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-ZETCQYMHSA-N 0.000 claims description 26
- 229960003080 taurine Drugs 0.000 claims description 25
- 239000004471 Glycine Substances 0.000 claims description 22
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 claims description 19
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 claims description 19
- 229930003427 Vitamin E Natural products 0.000 claims description 19
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 claims description 19
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 19
- 230000003301 hydrolyzing effect Effects 0.000 claims description 19
- 235000019155 vitamin A Nutrition 0.000 claims description 19
- 239000011719 vitamin A Substances 0.000 claims description 19
- 239000011691 vitamin B1 Substances 0.000 claims description 19
- 235000019165 vitamin E Nutrition 0.000 claims description 19
- 239000011709 vitamin E Substances 0.000 claims description 19
- 229940046009 vitamin E Drugs 0.000 claims description 19
- 229940045997 vitamin a Drugs 0.000 claims description 19
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 18
- 229930003268 Vitamin C Natural products 0.000 claims description 18
- 235000019154 vitamin C Nutrition 0.000 claims description 18
- 239000011718 vitamin C Substances 0.000 claims description 18
- KBPHJBAIARWVSC-RGZFRNHPSA-N lutein Chemical compound C([C@H](O)CC=1C)C(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C KBPHJBAIARWVSC-RGZFRNHPSA-N 0.000 claims description 17
- 229920001100 Polydextrose Polymers 0.000 claims description 15
- 239000001259 polydextrose Substances 0.000 claims description 15
- 235000013856 polydextrose Nutrition 0.000 claims description 15
- 229940035035 polydextrose Drugs 0.000 claims description 15
- 239000011715 vitamin B12 Substances 0.000 claims description 15
- 239000011726 vitamin B6 Substances 0.000 claims description 14
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims description 13
- 229920002774 Maltodextrin Polymers 0.000 claims description 13
- 239000005913 Maltodextrin Substances 0.000 claims description 13
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims description 13
- 229940035034 maltodextrin Drugs 0.000 claims description 13
- 229960003966 nicotinamide Drugs 0.000 claims description 13
- 235000005152 nicotinamide Nutrition 0.000 claims description 13
- 239000011570 nicotinamide Substances 0.000 claims description 13
- 229940055726 pantothenic acid Drugs 0.000 claims description 13
- 235000019161 pantothenic acid Nutrition 0.000 claims description 13
- 239000011713 pantothenic acid Substances 0.000 claims description 13
- 239000011716 vitamin B2 Substances 0.000 claims description 13
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 239000008103 glucose Substances 0.000 claims description 12
- 244000189799 Asimina triloba Species 0.000 claims description 9
- 235000006264 Asimina triloba Nutrition 0.000 claims description 9
- 241000901050 Bifidobacterium animalis subsp. lactis Species 0.000 claims description 9
- 235000009467 Carica papaya Nutrition 0.000 claims description 9
- 229940009289 bifidobacterium lactis Drugs 0.000 claims description 9
- 239000000284 extract Substances 0.000 claims description 9
- 229920001353 Dextrin Polymers 0.000 claims description 8
- 239000004375 Dextrin Substances 0.000 claims description 8
- 241000218588 Lactobacillus rhamnosus Species 0.000 claims description 8
- BUGBHKTXTAQXES-UHFFFAOYSA-N Selenium Chemical compound [Se] BUGBHKTXTAQXES-UHFFFAOYSA-N 0.000 claims description 8
- 235000019425 dextrin Nutrition 0.000 claims description 8
- 235000021255 galacto-oligosaccharides Nutrition 0.000 claims description 8
- 150000003271 galactooligosaccharides Chemical class 0.000 claims description 8
- 229910052711 selenium Inorganic materials 0.000 claims description 8
- 239000011669 selenium Substances 0.000 claims description 8
- 239000011647 vitamin D3 Substances 0.000 claims description 8
- 241000209140 Triticum Species 0.000 claims description 7
- 235000021307 Triticum Nutrition 0.000 claims description 7
- 230000035935 pregnancy Effects 0.000 claims description 7
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 6
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 claims description 6
- 230000000474 nursing effect Effects 0.000 claims description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 claims 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 claims 1
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 claims 1
- 241000186660 Lactobacillus Species 0.000 claims 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 claims 1
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims 1
- 229930003779 Vitamin B12 Natural products 0.000 claims 1
- FHCZILHPOKONMM-RGMNGODLSA-N [Zn].C(CC)N[C@@H](CCO)C(=O)O Chemical compound [Zn].C(CC)N[C@@H](CCO)C(=O)O FHCZILHPOKONMM-RGMNGODLSA-N 0.000 claims 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 claims 1
- 235000009508 confectionery Nutrition 0.000 claims 1
- 150000002148 esters Chemical class 0.000 claims 1
- 238000004108 freeze drying Methods 0.000 claims 1
- JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 claims 1
- 229940039696 lactobacillus Drugs 0.000 claims 1
- 235000012680 lutein Nutrition 0.000 claims 1
- 229960005375 lutein Drugs 0.000 claims 1
- ORAKUVXRZWMARG-WZLJTJAWSA-N lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C ORAKUVXRZWMARG-WZLJTJAWSA-N 0.000 claims 1
- 239000001656 lutein Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 229910052698 phosphorus Inorganic materials 0.000 claims 1
- 239000011574 phosphorus Substances 0.000 claims 1
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims 1
- KBPHJBAIARWVSC-XQIHNALSSA-N trans-lutein Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C(=CC(O)CC2(C)C)C KBPHJBAIARWVSC-XQIHNALSSA-N 0.000 claims 1
- 235000019163 vitamin B12 Nutrition 0.000 claims 1
- FJHBOVDFOQMZRV-XQIHNALSSA-N xanthophyll Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CC(O)CC1(C)C)C=CC=C(/C)C=CC2C=C(C)C(O)CC2(C)C FJHBOVDFOQMZRV-XQIHNALSSA-N 0.000 claims 1
- 239000000047 product Substances 0.000 abstract description 12
- 239000002994 raw material Substances 0.000 abstract description 7
- 238000001291 vacuum drying Methods 0.000 abstract description 7
- 239000004615 ingredient Substances 0.000 abstract description 6
- 238000010521 absorption reaction Methods 0.000 abstract description 4
- 235000016709 nutrition Nutrition 0.000 abstract description 4
- 239000013589 supplement Substances 0.000 abstract description 4
- 230000036541 health Effects 0.000 abstract description 3
- 239000000203 mixture Substances 0.000 abstract description 3
- 230000035764 nutrition Effects 0.000 abstract description 3
- 241000196324 Embryophyta Species 0.000 abstract description 2
- 239000002131 composite material Substances 0.000 abstract description 2
- 238000005516 engineering process Methods 0.000 abstract description 2
- 230000006872 improvement Effects 0.000 abstract description 2
- 235000013336 milk Nutrition 0.000 abstract description 2
- 239000008267 milk Substances 0.000 abstract description 2
- 210000004080 milk Anatomy 0.000 abstract description 2
- 230000008569 process Effects 0.000 abstract description 2
- 230000002195 synergetic effect Effects 0.000 abstract description 2
- 150000001720 carbohydrates Chemical class 0.000 abstract 1
- 235000014633 carbohydrates Nutrition 0.000 abstract 1
- 239000000126 substance Substances 0.000 description 8
- 238000011161 development Methods 0.000 description 5
- 230000018109 developmental process Effects 0.000 description 5
- MBMBGCFOFBJSGT-KUBAVDMBSA-N docosahexaenoic acid Natural products CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCC(O)=O MBMBGCFOFBJSGT-KUBAVDMBSA-N 0.000 description 5
- 210000004027 cell Anatomy 0.000 description 4
- 235000020669 docosahexaenoic acid Nutrition 0.000 description 4
- 210000001525 retina Anatomy 0.000 description 4
- 206010010774 Constipation Diseases 0.000 description 3
- 210000004556 brain Anatomy 0.000 description 3
- 235000020673 eicosapentaenoic acid Nutrition 0.000 description 3
- 210000003754 fetus Anatomy 0.000 description 3
- 235000013305 food Nutrition 0.000 description 3
- 210000004185 liver Anatomy 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 240000006240 Linum usitatissimum Species 0.000 description 2
- 235000004431 Linum usitatissimum Nutrition 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 210000004958 brain cell Anatomy 0.000 description 2
- 229940069978 calcium supplement Drugs 0.000 description 2
- 210000003792 cranial nerve Anatomy 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 239000000194 fatty acid Substances 0.000 description 2
- 230000001605 fetal effect Effects 0.000 description 2
- 235000004426 flaxseed Nutrition 0.000 description 2
- 210000002189 macula lutea Anatomy 0.000 description 2
- 230000002028 premature Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- YUFFSWGQGVEMMI-JLNKQSITSA-N (7Z,10Z,13Z,16Z,19Z)-docosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCCCC(O)=O YUFFSWGQGVEMMI-JLNKQSITSA-N 0.000 description 1
- ADVPTQAUNPRNPO-REOHCLBHSA-N 3-sulfino-L-alanine Chemical compound OC(=O)[C@@H](N)C[S@@](O)=O ADVPTQAUNPRNPO-REOHCLBHSA-N 0.000 description 1
- QCVGEOXPDFCNHA-UHFFFAOYSA-N 5,5-dimethyl-2,4-dioxo-1,3-oxazolidine-3-carboxamide Chemical compound CC1(C)OC(=O)N(C(N)=O)C1=O QCVGEOXPDFCNHA-UHFFFAOYSA-N 0.000 description 1
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 208000024172 Cardiovascular disease Diseases 0.000 description 1
- 208000032170 Congenital Abnormalities Diseases 0.000 description 1
- 101710088194 Dehydrogenase Proteins 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 235000021294 Docosapentaenoic acid Nutrition 0.000 description 1
- 102000002322 Egg Proteins Human genes 0.000 description 1
- 108010000912 Egg Proteins Proteins 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 206010040925 Skin striae Diseases 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- JAZBEHYOTPTENJ-JLNKQSITSA-N all-cis-5,8,11,14,17-icosapentaenoic acid Chemical compound CC\C=C/C\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O JAZBEHYOTPTENJ-JLNKQSITSA-N 0.000 description 1
- ADVPTQAUNPRNPO-UHFFFAOYSA-N alpha-amino-beta-sulfino-propionic acid Natural products OC(=O)C(N)CS(O)=O ADVPTQAUNPRNPO-UHFFFAOYSA-N 0.000 description 1
- 150000001412 amines Chemical class 0.000 description 1
- 230000001093 anti-cancer Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000003464 asthenopia Diseases 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000002457 bidirectional effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 210000004204 blood vessel Anatomy 0.000 description 1
- 230000004641 brain development Effects 0.000 description 1
- 201000011510 cancer Diseases 0.000 description 1
- 230000003915 cell function Effects 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000007812 deficiency Effects 0.000 description 1
- 238000001514 detection method Methods 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 230000029087 digestion Effects 0.000 description 1
- 229940090949 docosahexaenoic acid Drugs 0.000 description 1
- 231100000673 dose–response relationship Toxicity 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 235000014103 egg white Nutrition 0.000 description 1
- 210000000969 egg white Anatomy 0.000 description 1
- 229960005135 eicosapentaenoic acid Drugs 0.000 description 1
- JAZBEHYOTPTENJ-UHFFFAOYSA-N eicosapentaenoic acid Natural products CCC=CCC=CCC=CCC=CCC=CCCCC(O)=O JAZBEHYOTPTENJ-UHFFFAOYSA-N 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 238000007710 freezing Methods 0.000 description 1
- 230000008014 freezing Effects 0.000 description 1
- 230000005714 functional activity Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 208000004104 gestational diabetes Diseases 0.000 description 1
- 230000012010 growth Effects 0.000 description 1
- 235000020256 human milk Nutrition 0.000 description 1
- 210000004251 human milk Anatomy 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 230000008595 infiltration Effects 0.000 description 1
- 238000001764 infiltration Methods 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 230000000968 intestinal effect Effects 0.000 description 1
- 230000006651 lactation Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000035772 mutation Effects 0.000 description 1
- 230000005709 nerve cell growth Effects 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- -1 nicotinoyl Chemical group 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 235000019198 oils Nutrition 0.000 description 1
- 238000004321 preservation Methods 0.000 description 1
- 238000012545 processing Methods 0.000 description 1
- 239000002516 radical scavenger Substances 0.000 description 1
- 150000003254 radicals Chemical class 0.000 description 1
- 230000003014 reinforcing effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 230000002194 synthesizing effect Effects 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- 210000001550 testis Anatomy 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 235000021122 unsaturated fatty acids Nutrition 0.000 description 1
- 150000004670 unsaturated fatty acids Chemical class 0.000 description 1
- 230000004304 visual acuity Effects 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/20—Foods or foodstuffs containing additives; Preparation or treatment thereof containing gelling or thickening agents
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/125—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives containing carbohydrate syrups; containing sugars; containing sugar alcohols; containing starch hydrolysates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/135—Bacteria or derivatives thereof, e.g. probiotics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/20—Reducing nutritive value; Dietetic products with reduced nutritive value
- A23L33/21—Addition of substantially indigestible substances, e.g. dietary fibres
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/11—Lactobacillus
- A23V2400/175—Rhamnosus
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2400/00—Lactic or propionic acid bacteria
- A23V2400/51—Bifidobacterium
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Polymers & Plastics (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Nutrition Science (AREA)
- Mycology (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Inorganic Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Dispersion Chemistry (AREA)
- Botany (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Linolenic acid microcapsule powder and preparation method thereof and application method, provide making and using for the health care product that a kind of pair of alpha-linolenic acid is utilized, wherein, linolenic acid microcapsule powder is using linseed oil microcapsule powder as main material, it arranges in pairs or groups various carbohydrates, vitamin and other auxiliary materials, by vacuum drying, crushing, is uniformly mixed and is prepared, it is different according to the selection of raw material and proportion, different linolenic acid microcapsule powders can be made, the pregnant woman that different linolenic acid microcapsule powders are directed to different times respectively takes.The present invention uses microcapsule technology, saves linseed oil preferably;Using composite plant formula, pure and fresh milk, mouthfeel is more preferable, it is easier to absorption of human body;In process, carry out composition proportion improvement, while synergistic between each ingredient, product is not only rich in alpha-linolenic acid, while can the ingredients such as supplement calcium, folic acid, there is inoxidizability, more conducively absorption of the human body to nutrition.
Description
Technical field
The present invention relates to health product field, specially a kind of linolenic acid microcapsule powder and preparation method thereof and application method.
Background technique
Omega-fatty acid is mostly unsaturated fatty acid, is the core substance of life, is to maintain human body to evolve, keep body strong
The essential fatty acid of health, human body itself can not synthesize, and can only absorb from food to meet somagenic need.Alpha-linolenic acid is
" parent " of omega-fatty acid family, in human liver, desaturase and extend enzyme under the action of, can transform into
The vital activity factor-EPA(eicosapentaenoic acid needed by human, is commonly called as blood vessel scavenger) and DHA(docosahexaenoic acid,
It is commonly called as docosapentaenoic acid).World Science man to alpha-linolenic acid after more than 50 years the study found that alpha-linolenic acid to improve brain cell function
Can, improve memory, prevention senile dementia, prevention cardiovascular and cerebrovascular disease, cancer, diabetes etc. has remarkable result.It grinds
Study carefully and show that pregnant woman in pregnant advanced stage, can support fetal parts alpha-linolenic acid, fetus after itself liver has certain metabolic capability,
The alpha-linolenic acid in female blood is absorbed, is metabolized out the material composition of oneself brain cell needs, this has absolutely proved pregnant woman from pregnancy
To the necessity of nursing period supplement alpha-linolenic acid.
Having now found that has linseed oil containing the more substance of alpha-linolenic acid, although linseed oil has many health-care effects,
Since linseed oil is very low in the edible selection ratio of China, in storage, can also occur some chemical changes and
Nutritional ingredient is reduced, therefore, in order to preferably utilize this substance beneficial to human body, needs to take the processing work of microencapsulation
Linseed oil is processed into microcapsule powder by skill, is mixed with other ingredients, to produce linolenic acid microcapsule powder, both avoids part
The unacceptable special odor of crowd, and the loss of linseed oil nutriment during storage can be prevented.
Summary of the invention
For overcome the deficiencies in the prior art, the present invention provides a kind of linolenic acid microcapsule powder and preparation method thereof and user
Method.
In order to solve the above technical problems, technical solution proposed by the present invention are as follows:
A kind of linolenic acid microcapsule powder, is formed by the component proportion of following parts by weight:
1000 ~ 3000 parts of linseed oil microcapsule powder, 1000 ~ 3000 parts of maltodextrin, 0 ~ 1000 part of polydextrose, glucose 300 ~
1000 parts, 0 ~ 1000 part of galactooligosaccharide, 0 ~ 500 part of phosphatidase 5,1 ~ 10 part of taurine, 10 ~ 50 parts of vitamin C, vitamin A
0.1 ~ 1 part, 1 ~ 10 part of vitamin E, vitamin B10.1 ~ 1 part, vitamin B20 ~ 1 part, vitamin B60 ~ 1 part, vitamin B12
0 ~ 1 part, vitamin D30 ~ 1 part, 0 ~ 0.1 part of folic acid, 0 ~ 3 part of niacinamide, 0 ~ 1 part of pantothenic acid, 0 ~ 50 part of lutein ester, glycine
0 ~ 50 part of calcium, 0 ~ 50 part of glycine zine, 0 ~ 50 part of product containing organic selenium, 10 ~ 100 parts of hydrolyzing lactoalbumin, pawpaw powder extracts 0 ~ 20
Part, 0 ~ 20 part of Lactobacillus rhamnosus freeze-dried powder, 0 ~ 20 part of bifidobacterium lactis freeze-dried powder.
Further, the linolenic acid microcapsule powder includes formula A, formula B and formula C, wherein formula A is by following parts by weight
Several component proportions form: 1500 ~ 2500 parts of linseed oil microcapsule powder, 1500 ~ 2500 parts of maltodextrin, and glucose 500 ~ 800
Part, 50 ~ 400 parts of phosphatidase 1,5 ~ 10 parts of taurine, 20 ~ 40 parts of vitamin C, 0.1 ~ 0.5 part of vitamin A, vitamin E 1 ~ 5
Part, vitamin B10.1 ~ 0.5 part, vitamin B20.1 ~ 0.5 part, vitamin B60.1 ~ 0.5 part, vitamin B12 0.1~0.5
Part, 0.05 ~ 0.1 part of folic acid, 1.4 ~ 2.4 parts of niacinamide, 0.2 ~ 0.5 part of pantothenic acid, 20 ~ 40 parts of glycine zine, lutein ester 10 ~
50 parts, 10 ~ 50 parts of product containing organic selenium, 15 ~ 50 parts of hydrolyzing lactoalbumin;Formula B is formed by the component proportion of following parts by weight: sub-
1500 ~ 2500 parts of flaxseed oil microcapsule powder, 1500 ~ 2500 parts of maltodextrin, 500 ~ 800 parts of polydextrose, 50 ~ 400 parts of phosphatidase 1,
5 ~ 10 parts of taurine, 20 ~ 40 parts of vitamin C, 0.1 ~ 0.5 part of vitamin A, 1 ~ 5 part of vitamin E, vitamin B1 0.1~0.5
Part, vitamin B20.1 ~ 0.5 part, vitamin B60.1 ~ 0.5 part, 0.1 ~ 1 part of vitamin B12,0.05 ~ 0.1 part of folic acid, nicotinoyl
1.4 ~ 2.4 parts of amine, 0.2 ~ 0.5 part of pantothenic acid, 10 ~ 50 parts of lutein ester, 20 ~ 40 parts of calcium glycine, hydrolyzing lactoalbumin 15 ~ 50
Part;Formula C is formed by the component proportion of following parts by weight: 1500 ~ 2500 parts of linseed oil microcapsule powder, maltodextrin 1500 ~
2500 parts, 300 ~ 1000 parts of glucose, 500 ~ 800 parts of galactooligosaccharide, 50 ~ 400 parts of phosphatidase 1,5 ~ 10 parts of taurine, vitamin
20 ~ 40 parts of C, 0.1 ~ 0.5 part of vitamin A, 1 ~ 5 part of vitamin E, vitamin B10.1 ~ 0.5 part, vitamin D30.1~0.5
Part, 10 ~ 50 parts of lutein ester, 10 ~ 20 parts of pawpaw powder extracts, 20 ~ 40 parts of calcium glycine, Lactobacillus rhamnosus freeze-dried powder 10 ~
20 parts, 10 ~ 20 parts of bifidobacterium lactis freeze-dried powder, 15 ~ 50 parts of hydrolyzing lactoalbumin.
Further, the formula A of the linolenic acid microcapsule powder is formed by the component proportion of following parts by weight: linseed oil
2000 parts of microcapsule powder, 2000 parts of maltodextrin, 740 parts of polydextrose, 00 part of phosphatidase 2,8 parts of taurine, 20 parts of vitamin C, dimension
Raw 0. 1 parts of A of element, 2 parts of vitamin E, vitamin B10.2 part, vitamin B20.2 part, vitamin B60.2 part, vitamin B12
0.5 part, 0.08 part of folic acid, 1.65 parts of niacinamide, 0.4 part of pantothenic acid, 32 parts of glycine zine, 40 parts of product containing organic selenium, hydrolyzed whey egg
White 25 parts;The formula B of the linolenic acid microcapsule powder is formed by the component proportion of following parts by weight: linseed oil microcapsule powder 2000
Part, 2000 parts of maltodextrin, 740 parts of polydextrose, 00 part of phosphatidase 2,8 parts of taurine, 20 parts of vitamin C, vitamin A 0. 1
Part, 2 parts of vitamin E, vitamin B10.2 part, vitamin B20.2 part, vitamin B60.2 part, vitamin B120.5 part, leaf
0.08 part, 1.65 parts of niacinamide, 0.4 part of pantothenic acid, 40 parts of lutein ester, 32 parts of calcium glycine, 25 parts of hydrolyzing lactoalbumin of acid;
The formula C of the linolenic acid microcapsule powder is formed by the component proportion of following parts by weight: 2000 parts of linseed oil microcapsule powder, malt
2000 parts of dextrin, 740 parts of polydextrose, 450 parts of glucose, 600 parts of galactooligosaccharide, 00 part of phosphatidase 2,8 parts of taurine, dimension life
20 parts of plain C, 0. 1 parts of vitamin A, 2 parts of vitamin E, vitamin B10.2 part, vitamin D3 0.2 part, lutein ester 50
Part, 20 parts of pawpaw powder extracts, 32 parts of calcium glycine, 20 parts of Lactobacillus rhamnosus freeze-dried powder, 20 parts of bifidobacterium lactis freeze-dried powder,
25 parts of hydrolyzing lactoalbumin.
Linolenic acid microcapsule powder based on said ratio, preparation method are as follows: will be comprising each including linseed oil microcapsule powder
Kind material vacuum is dry, crushes, is uniformly mixed, and is made.
Based on the linolenic acid microcapsule powder that said ratio and preparation method obtain, application method are as follows: the linolenic acid for matching A is micro-
Capsule powder is applied to pregnant woman's standby pregnant phase to the pregnancy period three months, and the linolenic acid microcapsule powder for matching B is applied to four months pregnant woman's pregnancy periods to life
It produces, the linolenic acid microcapsule powder for matching C is applied to pregnant woman's nursing period.
In the present invention, alpha-linolenic acid is the core substance for constituting human body cell, it can be under the action of a variety of enzymes, in liver
It is dirty to be metabolized as DHA and EPA.DHA and EPA is the important component of the cell membranes such as brain, retina, all selective infiltration brain skin
In the vitals such as matter, retina, testis, sperm, participate in constituting sphingomylin and lipid sphyngomyelin.Alpha-linolenic acid can promote
The development of fetus cranial nerve (brain development) and retina;Prevent fetal anomaly and cell mutation, promotes fetal body development;Subtract
Light pregnant woman's pregnancy reaction, reduces striae of pregnancy, and postpartum body is promoted to restore;Prevent gestational diabetes mellitus, depression, constipation etc..
Polydextrose makes the necessary volume of product formation as thickener, and food product oil shape mouthfeel can be improved, have
Low freezing point, and not will lead to saprodontia, sugared in food, fat and starch dosage, with low in calories can be lowered.
Maltodextrin is easily absorbed by the body, make small product size expansion, prevented from caking, instant, brew is good, improve nutrition ratio
Valence.
Lutein ester protects macula lutea, promotes macula lutea development, promotes visual acuity, alleviates visual fatigue.
Calcium glycine belongs to novel calcium supplement, is easier to be absorbed by the body than other calcium supplements.
Taurine, in the rich content, widely distributed of intracerebral, the growth and development and cell that can be obviously promoted nervous system increase
It grows, break up, and be in dose dependent, play an important role in cranial nerve cell growth course.Research shows that: in premature's brain
Content of taurine is significantly lower than term infant, this is because the intracorporal cysteine sulfinic acid dehydrogenase (CSAD) of premature is not yet sent out
It is bred as ripe, synthesizing taurine is insufficient for the needs of body, need to be supplemented by breast milk;The maincenter mind of taurine and child, fetus
Through and the development of retina etc. have close relationship;Taurine has many cells of maintenance, especially haemocyte antioxidant activity, makes
Organize the damage from aoxidizing base and free radical.
Lactobacillus rhamnosus, enteron aisle definite value bacterium, bidirectional modulation diarrhea, constipation improve gastrointestinal function.
Bifidobacterium lactis, prevent constipation improve gastrointestinal tract, improve immunity.
Galactooligosaccharide, character are stablized, and provide energy for intestinal flora.
Pawpaw powder extracts, reinforcing spleen to promote digestion supplement the nutrients, promote lactation anticancer.
Compared with prior art, the invention has the advantages that
1. using microcapsule technology, the stability and water solubility of functional activity substance are improved, the linseed extracted in linseed is made
Oily more preferable preservation;2. using composite plant formula, pure and fresh milk, mouthfeel is more preferable, it is easier to absorption of human body;In process,
The improvement of certain composition proportion is carried out, while synergistic between each ingredient, product is not only rich in alpha-linolenic acid, while can
The ingredients such as supplement calcium, folic acid have inoxidizability, and various tastes can be made in more conducively absorption of the human body to nutrition, adapt to
In various crowds.
Specific embodiment
Below in conjunction with specific preferred embodiment, the invention will be further described, but not thereby limiting the invention
Protection scope.
Embodiment 1:
Linolenic acid microcapsule powder is formed: linseed oil microcapsule powder 1000g, wheat according to formula A by the component proportion of following parts by weight
Bud dextrin 1000g, glucose 300g, phosphatidase 5 0g, taurine 1g, vitamin C 10g, vitamin A 0.1g, vitamin E 1g,
Vitamin B10.1g, vitamin B20.1g, vitamin B60.1g, vitamin B120.03g, folic acid 0.01g, niacinamide 1g are general
Sour 0.1g, glycine zine 10g, hydrolyzing lactoalbumin 10g, product containing organic selenium 10g are equal by above-mentioned raw materials vacuum drying, crushing, mixing
It is even, it is made.
Embodiment 2:
Linolenic acid microcapsule powder is formed: linseed oil microcapsule powder 2000g, wheat according to formula A by the component proportion of following parts by weight
Bud dextrin 2000g, glucose 740g, phosphatidase 2 00g, taurine 8g, vitamin C 20g, vitamin A 0.1g, vitamin E 2g,
Vitamin B10.2g, vitamin B20.2g, vitamin B60.2g, vitamin B120.03g, folic acid 0.08g, niacinamide
1.65g, pantothenic acid 0.4g, glycine zine 32g, hydrolyzing lactoalbumin 25g, product containing organic selenium 10g, by above-mentioned raw materials vacuum drying, powder
It is broken, uniformly mixed, it is made.
Embodiment 3:
Linolenic acid microcapsule powder is formed: linseed oil microcapsule powder 1500g, wheat according to formula B by the component proportion of following parts by weight
Bud dextrin 1500g, polydextrose 500g, phosphatidase 1 50g, taurine 5g, vitamin C 20g, vitamin A 0.1g, vitamin E
1g, vitamin B10.1g, vitamin B20.1g, vitamin B60.1g, vitamin B120.5 part, folic acid 0.05g, niacinamide
1.4g, pantothenic acid 0.2g, calcium glycine 20g, lutein ester 40g, hydrolyzing lactoalbumin 15g, by above-mentioned raw materials vacuum drying, powder
It is broken, uniformly mixed, it is made.
Embodiment 4:
Linolenic acid microcapsule powder is formed: linseed oil microcapsule powder 2000g, wheat according to formula B by the component proportion of following parts by weight
Bud dextrin 2000g, polydextrose 740g, phosphatidase 2 00g, taurine 8g, vitamin C 20g, vitamin A 0.1g, vitamin E
2g, vitamin B10.2g, vitamin B20.2g, vitamin B60.2g, vitamin B120.03g, folic acid 0.08g, niacinamide
1.65g, pantothenic acid 0.4g, calcium glycine 32g, lutein ester 40g, hydrolyzing lactoalbumin 25g, by above-mentioned raw materials vacuum drying, powder
It is broken, uniformly mixed, it is made.
Embodiment 5:
Linolenic acid microcapsule powder is formed: linseed oil microcapsule powder 2500g, wheat according to formula C by the component proportion of following parts by weight
Bud dextrin 2500g, polydextrose 800g, glucose 300g, galactooligosaccharide 0.2g, phosphatidase 4 00g, taurine 10g, vitamin C
40g, vitamin A 0.5g, vitamin E 5g, vitamin B10.5g, vitamin D3 0.1g, vitamin B12 0.002g, lutein
Ester 0,5g, pawpaw powder extracts 2g, calcium glycine 40g, Lactobacillus rhamnosus freeze-dried powder 20g, bifidobacterium lactis freeze-dried powder 20g,
Hydrolyzing lactoalbumin 50g by above-mentioned raw materials vacuum drying, is crushed, uniformly mixed, is made.
Embodiment 6:
Linolenic acid microcapsule powder is formed: linseed oil microcapsule powder 2000g, wheat according to formula C by the component proportion of following parts by weight
Bud dextrin 2000g, polydextrose 740g, glucose 300g, galactooligosaccharide 0.2g, phosphatidase 2 00g, taurine 8g, vitamin C
20g, vitamin A 0.1g, vitamin E 2g, vitamin B10.2g, vitamin D3 0.1g, vitamin B12 0.002g, lutein
Ester 0.5g, pawpaw powder extracts 2g, calcium glycine 32g, Lactobacillus rhamnosus freeze-dried powder 20g, bifidobacterium lactis freeze-dried powder 20g,
Hydrolyzing lactoalbumin 25g by above-mentioned raw materials vacuum drying, is crushed, uniformly mixed, is made.
By embodiment 1-6 products obtained therefrom number consecutively A1-A6, the detection of related physical and chemical index and sanitary index, inspection are carried out
The results are shown in Table 1 for survey, meets index of correlation requirement.
1 A1-A5 physical and chemical index of table and sanitary index testing result
Above-mentioned, although specific embodiments of the present invention have been described, and it is not intended to limit the protection scope of the present invention, institute
Category field technical staff should be understood that based on the technical solutions of the present invention those skilled in the art do not need to pay wound
The various modifications or changes that the property made labour can be made are still within protection scope of the present invention.
Claims (5)
1. linolenic acid microcapsule powder, which is characterized in that formed by the component proportion of following parts by weight: linseed oil microcapsule powder 1000
~ 3000 parts, 1000 ~ 3000 parts of maltodextrin, 0 ~ 1000 part of polydextrose, 300 ~ 1000 parts of glucose, galactooligosaccharide 0 ~
1000 parts, 0 ~ 500 part of phosphatidase 5,1 ~ 10 part of taurine, 10 ~ 50 parts of vitamin C, 0.1 ~ 1 part of vitamin A, vitamin E 1 ~ 10
Part, vitamin B10.1 ~ 1 part, vitamin B20 ~ 1 part, vitamin B60 ~ 1 part, vitamin B120 ~ 1 part, vitamin D3 0~1
Part, 0 ~ 0.1 part of folic acid, 0 ~ 3 part of niacinamide, 0 ~ 1 part of pantothenic acid, 0 ~ 50 part of lutein ester, 0 ~ 50 part of calcium glycine, glycine zine 0
~ 50 parts, 0 ~ 50 part of product containing organic selenium, 10 ~ 100 parts of hydrolyzing lactoalbumin, 0 ~ 20 part of pawpaw powder extracts, Lactobacillus rhamnosus freeze-drying
0 ~ 20 part of powder, 0 ~ 20 part of bifidobacterium lactis freeze-dried powder.
2. linolenic acid microcapsule powder according to claim 1, which is characterized in that the linolenic acid microcapsule powder includes formula A, matches
Square B and formula C, wherein formula A is formed by the component proportion of following parts by weight: 1500 ~ 2500 parts of linseed oil microcapsule powder, wheat
1500 ~ 2500 parts of bud dextrin, 500 ~ 800 parts of glucose, 50 ~ 400 parts of phosphatidase 1,5 ~ 10 parts of taurine, 20 ~ 40 parts of vitamin C,
0.1 ~ 0.5 part of vitamin A, 1 ~ 5 part of vitamin E, vitamin B10.1 ~ 0.5 part, vitamin B20.1 ~ 0.5 part, vitamin B6
0.1 ~ 0.5 part, vitamin B12It is 0.1 ~ 0.5 part, 0.05 ~ 0.1 part of folic acid, 1.4 ~ 2.4 parts of niacinamide, 0.2 ~ 0.5 part of pantothenic acid, sweet
20 ~ 40 parts of propylhomoserin zinc, 10 ~ 50 parts of lutein ester, 10 ~ 50 parts of product containing organic selenium, 15 ~ 50 parts of hydrolyzing lactoalbumin;B is formulated by following
The component proportion of parts by weight forms: 1500 ~ 2500 parts of linseed oil microcapsule powder, 1500 ~ 2500 parts of maltodextrin, and polydextrose
500 ~ 800 parts, 50 ~ 400 parts of phosphatidase 1,5 ~ 10 parts of taurine, 20 ~ 40 parts of vitamin C, 0.1 ~ 0.5 part of vitamin A, vitamin
1 ~ 5 part of E, vitamin B10.1 ~ 0.5 part, vitamin B20.1 ~ 0.5 part, vitamin B60.1 ~ 0.5 part, vitamin B12 0.1
~ 1 part, 0.05 ~ 0.1 part of folic acid, 1.4 ~ 2.4 parts of niacinamide, 0.2 ~ 0.5 part of pantothenic acid, 10 ~ 50 parts of lutein ester, calcium glycine 20
~ 40 parts, 15 ~ 50 parts of hydrolyzing lactoalbumin;Formula C is formed by the component proportion of following parts by weight: linseed oil microcapsule powder
1500 ~ 2500 parts, 1500 ~ 2500 parts of maltodextrin, 300 ~ 1000 parts of glucose, 500 ~ 800 parts of galactooligosaccharide, phosphatidase 1 50 ~
400 parts, 5 ~ 10 parts of taurine, 20 ~ 40 parts of vitamin C, 0.1 ~ 0.5 part of vitamin A, 1 ~ 5 part of vitamin E, vitamin B1
0.1 ~ 0.5 part, vitamin D3 0.1 ~ 0.5 part, 10 ~ 50 parts of lutein ester, 10 ~ 20 parts of pawpaw powder extracts, calcium glycine 20 ~ 40
Part, 10 ~ 20 parts of Lactobacillus rhamnosus freeze-dried powder, 10 ~ 20 parts of bifidobacterium lactis freeze-dried powder, 15 ~ 50 parts of hydrolyzing lactoalbumin.
3. linolenic acid microcapsule powder according to claim 2, which is characterized in that the formula A of the linolenic acid microcapsule powder by with
The component proportion of lower parts by weight forms: 2000 parts of linseed oil microcapsule powder, 2000 parts of maltodextrin, and 740 parts of polydextrose, phosphorus
200 parts of rouge, 8 parts of taurine, 20 parts of vitamin C, 0. 1 parts of vitamin A, 2 parts of vitamin E, vitamin B10.2 part, dimension life
Plain B20.2 part, vitamin B60.2 part, vitamin B120.5 part, 0.08 part of folic acid, 1.65 parts of niacinamide, 0.4 part of pantothenic acid,
32 parts of glycine zine, 40 parts of product containing organic selenium, 25 parts of hydrolyzing lactoalbumin;The formula B of the linolenic acid microcapsule powder is by following weight
The component proportion of number forms: 2000 parts of linseed oil microcapsule powder, 2000 parts of maltodextrin, and 740 parts of polydextrose, phosphatidase 2 00
Part, 8 parts of taurine, 20 parts of vitamin C, 0. 1 parts of vitamin A, 2 parts of vitamin E, vitamin B10.2 part, vitamin B2
0.2 part, vitamin B60.2 part, vitamin B120.5 part, 0.08 part of folic acid, 1.65 parts of niacinamide, 0.4 part of pantothenic acid, lutein
40 parts of ester, 32 parts of calcium glycine, 25 parts of hydrolyzing lactoalbumin;The formula C of the linolenic acid microcapsule powder is by following parts by weight
Component proportion forms: 2000 parts of linseed oil microcapsule powder, 2000 parts of maltodextrin, 740 parts of polydextrose, 450 parts of glucose, low
600 parts of poly- galactolipin, 00 part of phosphatidase 2,8 parts of taurine, 20 parts of vitamin C, 0. 1 parts of vitamin A, 2 parts of vitamin E, dimension
Raw element B10.2 part, vitamin D3 0.2 part, 50 parts of lutein ester, 20 parts of pawpaw powder extracts, 32 parts of calcium glycine, rhamnose
20 parts of lactobacillus freeze-dried powder, 20 parts of bifidobacterium lactis freeze-dried powder, 25 parts of hydrolyzing lactoalbumin.
4. the preparation method of linolenic acid microcapsule powder a method according to any one of claims 1-3, which is characterized in that will include linseed oil
Various material vacuums including microcapsule powder are dry, crush, are uniformly mixed, and are made.
5. the application method of linolenic acid microcapsule powder as claimed in claim 2 or claim 3, which is characterized in that match the linolenic acid micro-capsule of A
Powder is applied to pregnant woman's standby pregnant phase to the pregnancy period three months, and the linolenic acid microcapsule powder for matching B arrived production applied to four months pregnant woman's pregnancy periods,
The linolenic acid microcapsule powder for matching C is applied to pregnant woman's nursing period.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811192556.XA CN108968072A (en) | 2018-10-13 | 2018-10-13 | Linolenic acid microcapsule powder and preparation method thereof and application method |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201811192556.XA CN108968072A (en) | 2018-10-13 | 2018-10-13 | Linolenic acid microcapsule powder and preparation method thereof and application method |
Publications (1)
Publication Number | Publication Date |
---|---|
CN108968072A true CN108968072A (en) | 2018-12-11 |
Family
ID=64543597
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201811192556.XA Pending CN108968072A (en) | 2018-10-13 | 2018-10-13 | Linolenic acid microcapsule powder and preparation method thereof and application method |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108968072A (en) |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109645486A (en) * | 2019-01-04 | 2019-04-19 | 达利园医药科技有限公司 | A kind of effective prescription and preparation method for supplementing maternal nutritional and promoting infants growth and development |
CN110179126A (en) * | 2019-05-29 | 2019-08-30 | 山东腾贵医药有限公司 | A kind of post-operative recovery preparation and preparation method thereof |
CN112056408A (en) * | 2020-09-03 | 2020-12-11 | 山东哈维药业有限公司 | Compound protein nutrient for female pregnancy preparation and preparation method thereof |
CN114246338A (en) * | 2021-12-01 | 2022-03-29 | 欣安贝药业科技盐城有限公司 | Preparation method and device of composite linseed oil microcapsule powder |
CN115153013A (en) * | 2022-07-25 | 2022-10-11 | 内蒙古金格勒食品有限公司 | Dietary nutritional granules for pregnant women and preparation method thereof |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103169733A (en) * | 2011-12-26 | 2013-06-26 | 浙江贝因美科工贸股份有限公司 | Compound probiotic, application thereof for treating anaphylactic diseases and allergy free probiotic electuary for pregnant and lying-in women |
CN106617075A (en) * | 2017-01-18 | 2017-05-10 | 济南善恩医药科技有限公司 | Compounded flax-seed oil microcapsule powder and preparation method thereof |
CN107432478A (en) * | 2017-07-28 | 2017-12-05 | 山东冠秀生物科技有限公司 | A kind of compound linseed oil microcapsule powder and preparation method thereof |
-
2018
- 2018-10-13 CN CN201811192556.XA patent/CN108968072A/en active Pending
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN103169733A (en) * | 2011-12-26 | 2013-06-26 | 浙江贝因美科工贸股份有限公司 | Compound probiotic, application thereof for treating anaphylactic diseases and allergy free probiotic electuary for pregnant and lying-in women |
CN106617075A (en) * | 2017-01-18 | 2017-05-10 | 济南善恩医药科技有限公司 | Compounded flax-seed oil microcapsule powder and preparation method thereof |
CN107432478A (en) * | 2017-07-28 | 2017-12-05 | 山东冠秀生物科技有限公司 | A kind of compound linseed oil microcapsule powder and preparation method thereof |
Cited By (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN109645486A (en) * | 2019-01-04 | 2019-04-19 | 达利园医药科技有限公司 | A kind of effective prescription and preparation method for supplementing maternal nutritional and promoting infants growth and development |
CN110179126A (en) * | 2019-05-29 | 2019-08-30 | 山东腾贵医药有限公司 | A kind of post-operative recovery preparation and preparation method thereof |
CN112056408A (en) * | 2020-09-03 | 2020-12-11 | 山东哈维药业有限公司 | Compound protein nutrient for female pregnancy preparation and preparation method thereof |
CN114246338A (en) * | 2021-12-01 | 2022-03-29 | 欣安贝药业科技盐城有限公司 | Preparation method and device of composite linseed oil microcapsule powder |
CN115153013A (en) * | 2022-07-25 | 2022-10-11 | 内蒙古金格勒食品有限公司 | Dietary nutritional granules for pregnant women and preparation method thereof |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108968072A (en) | Linolenic acid microcapsule powder and preparation method thereof and application method | |
CN102742837B (en) | Health food used for improving symptom of malnutrition and preparation method thereof | |
CN101791125B (en) | Functional nutriment for promoting lactation and recuperation of postpartum women and preparation method thereof | |
CN102429023B (en) | Milk companion of infant formula milk powder and preparation method thereof | |
CN105076490A (en) | Low-cholesterol nutrient health-care peanut oil and preparing method thereof | |
CN107853525A (en) | More nutritious food solid beverages that a kind of natural plants based on Konjak dietary fiber are made | |
CN103989174A (en) | Moringa oleifera composite all-nutrition nutrient | |
CN101283816A (en) | Instant sea tangle food and its processing method thereof | |
CN106617075A (en) | Compounded flax-seed oil microcapsule powder and preparation method thereof | |
CN102511864B (en) | Jujube high-consistency stock | |
CN102511861A (en) | Thickened red jujube pulp added with oligosaccharide | |
CN105076486A (en) | Blood-fat-reducing peanut oil rich in curcumin and resveratrol and preparation method thereof | |
CN109699745A (en) | A kind of fucosylated oligosaccharide baby formula milk powder and preparation method thereof | |
CN105087139A (en) | Peanut oil with effects of invigorating spleen and nourishing liver and making method thereof | |
CN105558260B (en) | Potato peptide nutrient food and preparation method thereof | |
CN103976205A (en) | Jelly for improving internal secretion and preparation method of jelly | |
CN102511882A (en) | Red jujube thick syrup beneficial for improving growth and development | |
CN102511860B (en) | Thickened red jujube pulp added with phytosterin and being suitable for being taken by pregnant women | |
CN100367865C (en) | Method for preparing digestion-promoting spleen-invigorating soybean milk powder with micron chickens gizzard-membrane powder, coix seed powder, white hyacinth bean powder, yam powder and pine pollen | |
CN110463782A (en) | A kind of synthesis olive oil and preparation method thereof | |
CN103843907A (en) | Kiwi fruit health protection milk slice | |
CN102511859A (en) | Jujube high-consistency stock with docose hexaenoie acid (DHA) being suitable for pregnant women and breast-feeding women to eat | |
CN107467654A (en) | One main laminaria sea cucumber composite extract and its preparation method and application | |
CN100333656C (en) | Method for preparing milk tablets contg. composite micron pollen pini and konjak for reducing-weight and lowering blood-sugar | |
CN105076492A (en) | Peanut oil capable of improving immunologic function and preparing method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |